Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establish a New Noninvasive Diagnostic Model Based on Common Clinical Indicators to Evaluate the Liver Fibrosis in Patients With Chronic Hepatitis B

NCT05560503 is registered in ClinicalTrials.gov with Xiangya Hospital of Central South University as lead sponsor.

NCT NCT05560503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05560503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establish a New Noninvasive Diagnostic Model Based on Common Clinical Indicators to Evaluate the Liver Fibrosis in Patients With Chronic Hepatitis B
Lead sponsor
Xiangya Hospital of Central South University
Phase
Observational
Overall status
Completed
Start date
January 1, 2017
Completion date
May 30, 2022
Enrollment
259 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

liver fibrosis